Harel Insurance Investments and Financial Services
Other
Active
Ramat Gan, Israel
26
66M
23
0.29
4
0.12
5
- Areas of investment
Summary
In 1982 was created Harel Insurance Investments and Financial Services, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in Israel. The main department of described Corporate Investor is located in the Tel Aviv.
The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Harel Insurance Investments and Financial Services performs on 12 percentage points less the average number of lead investments. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2019. The typical startup value when the investment from Harel Insurance Investments and Financial Services is 500 millions - 1 billion dollars.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Harel Insurance Investments and Financial Services, startups are often financed by Magna International, Zohar Zisapel, Vertex Ventures Israel. The meaningful sponsors for the fund in investment in the same round are SBI Japan-Israel Innovation Fund, Israel Biotech Fund, aMoon Fund. In the next rounds fund is usually obtained by Psagot Investment House, Meitav Investment House.
Among the most popular portfolio startups of the fund, we may highlight Enlight Renewable Energy, Ecoppia, Biond Biologics. Among the most successful fund investment fields, there are Environmental Engineering, Web Development. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. The fund has exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Investor highlights
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 26
- Lead investments
- 4
- Exits
- 5
- Rounds per year
- 0.29
- Follow on index
- 0.12
- Investments by industry
- Software (4)
- Biotechnology (4)
- Health Care (4)
- FinTech (4)
- Pharmaceutical (3) Show 53 more
- Investments by region
-
- Israel (19)
- United States (4)
- Australia (2)
- Peak activity year
- 2021
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 288M
- Group Appearance index
- 0.88
- Avg. company exit year
- 20
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Biond Biologics | 03 Nov 2021 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 15M | North District, Misgav Regional Council, Israel |
| Lumi Finance | 21 Jul 2023 | Financial Services, FinTech | Late Stage Venture | 10M | New South Wales, Sydney, Australia |
| Pineapple | 31 Jan 2022 | Manufacturing, Cannabis | Seed | 334K | United States, California, Los Angeles |
| Qwest (YC W19) | 18 Mar 2019 | Mobile, Events, Social Media | Seed | 150K | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.